Second Lab This Week Wants Bulk Controlled Substance License
Published Date: 11/26/2025
Notice
Summary
Irvine Labs, Inc. wants to become a big-time maker of marijuana and related substances for research. People already registered or interested can share their thoughts or ask for a hearing by January 26, 2026. This move could boost research supplies but won’t affect other drug activities or costs right now.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Application to Manufacture Schedule I Cannabis
On October 6, 2025, Irvine Labs, Inc. applied to be registered as a bulk manufacturer of Schedule I substances: Marihuana Extract (code 7350), Marihuana (code 7360), and Tetrahydrocannabinols (code 7370). The company says it plans to manufacture bulk active pharmaceutical ingredients for product development and to distribute them to DEA-registered researchers.
Registration Limited to Research Manufacture/Distribution
If registered, Irvine Labs would be authorized only to manufacture bulk active pharmaceutical ingredients for product development and to distribute them to DEA-registered researchers; no other activities for these drug codes are authorized.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in